Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Jan 18, 2017, 08:00 ET Tarix Orphan Receives Rare Pediatric Disease Designation for TXA127 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Tarix Orphan LLC today announced that the U.S. Food and Drug Administration has granted a Rare Pediatric Disease (RPD) designation for the...


Jan 18, 2017, 08:00 ET Daiichi Sankyo Initiates Phase 1/2 Study of Novel Antibody Drug Conjugate U3-1402 in Patients with HER3-Positive Metastatic or Unresectable Breast Cancer

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today the initiation of a three-part open-label phase 1/2 study in Japan with...


Jan 18, 2017, 08:00 ET Bayer to Present Latest Stivarga Data at ASCO GI 2017

Bayer announced today that the company will present seven abstracts on Stivarga® (regorafenib) in advanced liver and colorectal cancers at the 2017...


Jan 18, 2017, 08:00 ET New Outcomes Data Using Delcath's Melphalan/HDS To Treat Unresectable Metastatic Ocular Melanoma To The Liver Accepted For Oral Presentation At Regional Cancer Therapies Symposium

Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, today...


Jan 18, 2017, 08:00 ET FDA Grants Fast Track Designation for aTyr's Resolaris™ to Treat Limb Girdle Muscular Dystrophy 2B and Removes Partial Clinical Hold for Resolaris

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address...


Jan 18, 2017, 07:30 ET Asterias Announces Conference Call to Discuss 6-month Efficacy Data from AST-OPC1 SCiStar Study

FREMONT, Calif., Jan. 18, 2017 /PRNewswire/ -- Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company pioneering the field of...


Jan 18, 2017, 06:53 ET Dopo avere ottenuto la certificazione CE, Medasense lancia un nuovo dispositivo di monitoraggio del dolore, il PM D200[TM]

- La nuova tecnologia all'avanguardia aiuta gli esperti a offrire trattamenti del dolore personalizzati Medasense Biometrics Ltd. ha...


Jan 18, 2017, 06:45 ET Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid

Eli Lilly and Company (NYSE: LLY) and CoLucid Pharmaceuticals, Inc. (NASD: CLCD) today announced an agreement for Lilly to acquire CoLucid for...


Jan 18, 2017, 06:43 ET Medasense lance un nouveau dispositif de surveillance de la douleur, le PMD200[TM], après obtention de la certification européenne CE

- Une nouvelle technologie de pointe aide les cliniciens à soulager la douleur de leurs patients en fonction de leurs besoins Medasense...


Jan 18, 2017, 05:22 ET Medasense launch PMD200[TM] nach CE-Kennzeichung in Europa, neues Produkt zur Schmerzmessung

- Neue hochmoderne Technologie ermöglicht personalisierte Schmerzlinderung durch den Arzt Wie Medasense Biometrics Ltd. heute bekanntgab, hat es...


Jan 17, 2017, 16:02 ET Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating Defibrotide for the Potential Prevention of VOD in High Risk Patients

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in a Phase 3 clinical trial comparing the...


Jan 17, 2017, 16:01 ET Neurocrine Announces Completion of Phase II Clinical Study of VMAT2 Inhibitor INGREZZA™ (valbenazine) in Adults with Tourette Syndrome

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today the top-line results from the Company's Phase II T-Forward study of INGREZZA™...


Jan 17, 2017, 11:41 ET Well-Controlled Clinical Study Published by Journal of Clinical Orthodontics Demonstrates Effect of Vibration on Molar Distalization Using AcceleDent

Dr. S. Jay Bowman authors prospective, peer-reviewed clinical study that follows the treatment of 60 adolescent patients OrthoAccel®...


Jan 17, 2017, 09:11 ET Northwell Health Partners with Indivumed to Create a Cancer Research Biobank

Northwell Health today announced a collaboration with Indivumed to speed the advance of precision cancer research. As New York State's largest...


Jan 17, 2017, 09:00 ET Agenus announces collaboration with the National Cancer Institute to evaluate the combination of Pembrolizumab (Keytruda®, Merck & Co., Inc.) with Prophage™ (Agenus Inc.) autologous vaccine

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, today announced a...


Jan 17, 2017, 08:30 ET CSSi to Exhibit at 8th Annual SCOPE Summit in Miami, FL

CSSi, the global leader in patient recruitment, enrollment and retention solutions for the clinical research industry, will exhibit at the...


Jan 17, 2017, 08:00 ET Protagonist Therapeutics Initiates Phase 2b Study of Oral Drug Candidate PTG-100 in Ulcerative Colitis

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) today announced that it has initiated a global Phase 2b induction study in ulcerative colitis with...


Jan 17, 2017, 08:00 ET Natera Announces Results From DNAFirst Study, Validating Use Of NIPT In Routine Prenatal Care

Natera, Inc., (NASDAQ: NTRA), a leader in non-invasive genetic testing, today announced the results from the DNAFirst trial, showing that...


Jan 17, 2017, 08:00 ET New Data Confirms Abbott's Dorsal Root Ganglion Stimulation Offers Greater Treatment Success over Traditional Spinal Cord Stimulation

New data published in the January edition of Pain has confirmed the superiority of Abbott's dorsal root ganglion (DRG) stimulation therapy over...


Jan 17, 2017, 07:30 ET Panacea Pharmaceuticals Initiates Phase I Study of First-in-Class Cancer Vaccine Therapy Candidate in Patients with Persistent Prostate Cancer

Panacea Pharmaceuticals, a clinical stage biopharmaceutical company developing novel biologically targeted cancer therapies and diagnostics for...